Skip to content Learn about the access keys available for Aristotle.Cloud
This item has been superseded by a newer version by one or more Registration Authorities.

Definition

The chemotherapeutic agent or anti-cancer drug used for treatment of the primary cancer, as represented by a code.

Components

Data Element (this item)

Comments

Guide for use:

The purpose of collecting specific treatment information is to account for all treatment types, which may assist in evaluation of effectiveness of different treatment patterns. The actual agents used will sometimes be of interest.

Systemic therapy often involves treatment with a combination of agents. These may be known by acronyms but since details of drugs and acronyms may vary it is recommended that each agent be recorded separately.

Oral chemotherapy normally given on an outpatient basis should also be included.

New codes and names will need to be added as new agents become available for clinical use.

Hormone therapy agents and immunotherapy agents should be recorded under this data element.

Origin:

National Cancer Institute Surveillance, Epidemiology and End Results (SEER) Program

Comments:

Collecting dates for systemic therapy will allow evaluation of treatments delivered and of time intervals from diagnosis to treatment, from treatment to recurrence and from treatment to death.

References

Surveillance, Epidemiology and End Results (SEER) Program Self-instructional manual for tumour registrars: Book 8 - Antineoplastic drugs 3rd Edition National Cancer Institute.


This content Based on Australian Institute of Health and Welfare material. Attribution provided as required under the AIHW CC-BY licence.

Related content

Relation Count
Input in Derivations 0
Output in Derivations 0
Inclusion in Data Set Specifications 5
Inclusion in Data Distributions 0
As a numerator in an Indicator 0
As a denominator in an Indicator 0
As a disaggregation in an Indicator 0